STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1305 by analyst upside · 2026-06-27
OFIX
Orthofix Medical Inc.
Healthcare · Market Cap $395M · P/E 0x
ANALYST PRICE TARGET
+53.4%
implied upside to consensus target
Current Price $9.78
Consensus Target $15.0
Bull Target $18.0
Bear Target $12.0
Analysts Covering 4
ANALYST CONSENSUS — BUY
Strong Buy
1
Buy
2
Hold
2
Sell
0
52-Week Low $8.85
52-Week High $16.99
YTD Return -34.1%
FUNDAMENTALS
Market Cap $395M
P/E Ratio (TTM) N/A
Forward P/E 13.8x
EPS (TTM) $-1.50
PEG Ratio 48.83
Dividend Yield N/A
Revenue (TTM) $825M
Profit Margin -7.3%
52-WEEK RANGE
52-Week Low $8.85
52-Week High $16.99
Current Price $9.78
Bear Target $12.0
Bull Target $18.0
● Now $9.78 ● Target $15.0
TRADING DATA
Avg Volume 366K
YTD Return -34.1%
Analyst Count 4
Consensus Buy
Upside to Target +53.4%
Last Updated 2026-06-27

ANALYST SUMMARY

Orthofix Medical Inc. (OFIX) is currently trading at $9.78 with a Wall Street consensus price target of $15.0, implying potential upside of 53.4% over the next 12 months. 4 analysts currently cover OFIX, with a consensus rating of Buy — 60% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $18.0, while the most cautious has a target of $12.0.

OFIX operates in the Healthcare sector with a market capitalisation of $395M. The stock is down 34.1% year-to-date and is currently trading near the lower end of its 52-week range of $8.85 – $16.99.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for OFIX, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Canaccord Genuity — Reiterated
Buy → Buy 2026-05-22 Building track record
Barrington Research — Reiterated
Outperform → Outperform 2026-05-22 Building track record
Stifel — Reiterated
Buy → Buy 2026-05-22 Building track record
Barrington Research — Reiterated
Outperform → Outperform 2026-04-10 Building track record
Stifel — Reiterated
Buy → Buy 2026-03-09 Building track record
Canaccord Genuity — Reiterated
Buy → Buy 2026-02-26 Building track record
Barrington Research — Reiterated
Outperform → Outperform 2026-02-25 Building track record
Barrington Research — Reiterated
Outperform → Outperform 2026-02-17 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →